Back to search results

Dietary Fiber and Sarcopenia Risk in Head and Neck Cancer

This observational study is looking at how the amount of dietary fiber you eat might affect sarcopenia (muscle wasting) in people with newly diagnosed head and neck cancer. Researchers want to see if eating more fiber can help reduce muscle loss. They will track your dietary fiber intake and your muscle mass over six months. The study aims to understand the connection between fiber, inflammation, and muscle health. To join, you need to be at least 18 years old, have a new diagnosis of certain head and neck cancers, and be able to meet most of your energy needs. The study is currently unclear about its recruitment status.

Study design
This is an observational study with a planned enrollment of 59 participants. It will track dietary fiber intake and skeletal muscle index over six months.
What's involved
You would provide data at the start of the study, and then at 3 and 6 months after enrollment. This includes remote interviews and providing data before treatment.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for six months after enrollment, with measurements taken at baseline, 3 months, and 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07622914

The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer

Recruiting
Not specifiedAges 18+Observational
University of Oklahoma
~59 participants
Updated 2026-06-03 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Dietary Fiber Intake (mean for 30 days)
Measured over Baseline/upon enrollment, 3-months post-enrollment, and 6-months post-enrollment
+1 more outcome measured

Conditions

Head and Neck Cancers

Explore related trials

Head and Neck Squamous Cell Carcinoma

Where it's being run

1 sites across 1 states
Oklahoma1

Who to contact

Ashlea C Braun, PhD
[email protected]
15672401582
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

≥18 years of age
Newly diagnosed with squamous cell carcinoma of the: paranasal sinuses, nasal cavity, oral cavity, tongue, larynx, pharynx \[i.e., nasopharynx, oropharynx, hypopharynx\]
Meeting at least 60% of baseline energy needs
Willingness to provide data prior to treatment
Access to the internet
Access to a home freezer
Ability to do remote interview
Access to a phone
Willingness to avoid pre-, pro-, or synbiotics

Exclusion

Previously diagnosed or positive screen for a GI-related condition or eating disorder
Able to complete bioelectrical impedance (stand unsupported, no pacemaker or limb amputation) and Timed Chair Stands
Currently pregnant, planning to become pregnant, or breastfeeding
Current or past 3-month antibiotic use

What this trial measures

  • Dietary Fiber Intake (mean for 30 days)Baseline/upon enrollment, 3-months post-enrollment, and 6-months post-enrollment

    Reported dietary fiber intake (grams per day) will be measured using the Diet History Questionnaire 3 (DHQ3) to provide a mean value consumed per day over 30 days

  • Skeletal Muscle Index (SMI)Baseline, 3-months post-enrollment, 6-months post-enrollment

    Calculated using skeletal muscle area generated via software-based analysis of CT scans at the mid-third lumbar vertebra (L3) slice and height (in centimeters) as an indicator of sarcopenia (muscle quantity)